E-drug: 2003 SEAM Conference Update
-------------------------------------------------------------------------
Fellow E-ruggers:
Listed below is a list of the speakers and topics being given at the
2003 SEAM Conference being held June 16-18, 2003 in Dar es
Salaam, the United Republic of Tanzania. Organizations collaborating
on the 2003 Conference include the Ministry of Health of the United
Republic of Tanzania, the World Health Organization's Department of
Essential Drugs and Medicines Policy (WHO/EDM), the Rockefeller
Foundation, the International Network for Rational Use of Drugs
(INRUD), and the Rational Pharmaceutical Management Plus (RPM
Plus) and Strategies for Enhancing Access to Medicines (SEAM)
Programs of Management Sciences for Health (MSH).
Centering around the theme of "Targeting Improved Access", the
2003 Conference will convene key stakeholders to discuss ways to
advance access to essential medicines in developing countries,
address the concerns of pharmaceutical procurement and pricing,
and ensure effective pharmaceutical management systems. The
conference will also provide the opportunity to share information
about the activities of various initiatives which focus on increasing
access to essential medicines. The conference is particularly timely in
light of the increased flow of funding through the Global Fund to Fight
AIDS, Tuberculosis and Malaria, as well as other efforts to improve
access to medicines.
Registration is currently at full capacity, but we will be accepting new
registrants in the order in which they register as others decline. More
information about the conference structure, logistics, and registration
can be found at the website (www.msh.org/seam/conference).
SEAM 2003 Conference
General plenary presentation topics
1. General oOverview of pharmaceutical access issues from the
developing country perspective (Peter Mugyenyi, Joint Clinical
Research Center, Uganda-Confirmed)
2. The effective role of the private sector in public supply of medicines
(Denis Broun, MSH Europe-Confirmed)
3. Strengthening health commodity systems to support the
introduction of ARVs: Experiences from the front line (Chris Ouma,
ActionAid, Kenya-Confirmed)
4. The role importance of pharmaceutical system diagnostics:
Measuring supply system performance (Anthony Boni,
USAID-Confirmed)
5. Medicines financing and household expenses: Who pays for
medicines and is it enough?
6. Human rights and access to medicines: The consumer's
perspective
7. Effective drug regulation in the real world (Lembit Rago,
WHO/EDM-Confirmed)
8. The current situation in drug pricing: What's happening and where
do we go from here? (Jonathan Quick, WHO/EDM-Confirmed)
9. Global Fund to Fight AIDS, Tuberculosis and Malaria: Implications
for funding and procurement policies (GFATM speaker-Invited)
10. Monitoring access to essential medicines
a. The developing country perspective and experience (Joseph
Serutoke, Uganda-Confirmed)
b. Measures and methods (David Lee, MSH/CPM-Confirmed)
Parallel track presentation topics-
1. Overview of supply system models (Malcolm Clark,
MSH/SEAM-Confirmed)
2. Essential drug franchises
a. The experience with community health workers in Kenya (Liza
Kimbo, SHEF, Kenya-Confirmed)
b. Developing a chemical sellers' franchise in Ghana (Alex Banful,
GSMF, Ghana-Confirmed)
3. Improving access to medicines in rural areas: The Tanzanian
experience (Romuald Mbwasi, SEAM/Tanzania-Confirmed)
4. Use of community health promoters to distribute co-trimoxazole in
Senegal (Emmanuel Wansi, BASICS-Confirmed)
5. Public sector supply in a decentralized environment: The
experience in El Salvador (Francisco Lopez Beltran, MOH, El
Salvador-Confirmed)
6. Pharmaceutical industry supply initiatives: Lessons learned
(Sowedi Muyingo, Axios International-Confirmed)
Topic #2-Rational Use of Medicines
1. Introduction: Overview of rational drug use (Dennis Ross-Degnan,
Harvard University, Boston-Confirmed)
2. Evidence-based decision making and application of
pharmacoeconomic principles in drug selection (Gavin Steel, South
Africa-Confirmed)
3. Current approaches to selection and treatment guidelines:
Examples from India (Sangeeta Sharma, Delhi Society for Promoting
Rational Use of Drugs, India-Confirmed)
4. Utility and use of community assessment data to enhance the
rational use of drugs
a. An assessment tool (Jane Briggs, MSH/RPM Plus-Confirmed)
b. The Senegal experience (Issa Diop, MOH, Central Stores,
Senegal-Confirmed)
5. Antimicrobial resistance and rational drug use: What are the
issues/problems and how can they be addressed? (Mohan Joshi,
MSH/RPM Plus-Confirmed)
6. Antimicrobial resistance and rational drug use: What are the
issues/problems and how can they be addressed?
7. Role of regulatory authorities in promoting rational use of drugs
(Sauwakon Ratananwijitrasin, Chualongkorn University,
Thailand-Confirmed)
Topic #3--Pharmaceutical Procurement
1. Overview of procurement and pooled procurement models (Andrew
Barraclough, MSH/M&L, Indonesia-Confirmed)
2. Doha Declaration on TRIPS/Public Health: Overview and status of
follow-up initiatives, both national and global, and their influence on
procurement of patent-protected pharmaceuticals (Ellen 't Hoen,
MSF, France-Confirmed)
3. Development and testing of a prequalification procedure for
HIV/AIDS, TB, and malaria products and manufacturers (Andre van
Zyl, WHO/EDM-Confirmed)
4. Lessons learned from regional pooled procurement efforts: What
are the criteria for success? Where does pooled procurement fail?
(Francis Burnett, OECS/PPS, St. Lucia-Confirmed)
5. Pooled procurement initiatives of the Commonwealth Regional
Health Community Secretariat (Bannet Ndyanabangi, CRHCS,
Tanzania-Confirmed)
6. Integration of vertical disease-related procurement systems into
mainstream procurement efforts (Christopher Msemo, Medical Stores
Department, Tanzania-Invited)
Topic #4-Human Resources for the Pharmaceutical Sector
1. Human resources for the pharmaceutical sector: Issues,
challenges, and opportunities (Eva Ombaka, EPN, Kenya-Confirmed)
2. Human capacity development as an effective response to
HIV/AIDS: Human resources implications of scaling up care for
HIV/AIDS (Paula Munderi, Uganda-Confirmed)
3. Utilizing a team approach to meet human resource needs in the
pharmaceutical sector: Role and function of physicians and
pharmacists in rational use of drugs (David Ofori-Adjei, Noguchi
Memorial Institute for Medical Research, Ghana-Confirmed)
4. Increased availability and improved quality of drugs at the
community level through drug sellers to meet human resource needs:
The experience of a Nigerian community-based intervention in the
management of malaria (George Greer,
BASICS-Confirmed)Licensing and certification of drug sellers:
Innovative approaches
5. Employment opportunities, career development, and preventing
"brain drain" (Mabel Torongo, Zimbabwe-Confirmed)
Topic #5-Pharmaceutical Product Quality Assurance
1. Quality assurance in practice: Product quality standards and
bioequivalence issues. Scope of the problem and possible means to
help address the problem areas (Thomas Layloff,
MSH/SEAM-Confirmed)
2. Registration, inspection, and testing resource allocations: How to
triage? (Souly Phanouvong, USP-Confirmed)
3. To be GMP or not to be GMP compliant? Relative risks of
noncompliance and role of WHO basic GMP-training modules
a. Regulatory perspective (Charles Kandie, WHO, Kenya-Confirmed)
b. Manufacturing perspective (Eloan Pinheiro, Brazil-Confirmed)
4. Product quality assessment tools: Mini-labs as a component of
quality monitoring. Experiences and methodological issues (Zera
Msuya, Pharmacy Board, Tanzania-Confirmed)
5. Infrastructure development: Training and competency assessment
Topic #6-Pharmaceutical Product Prices
1. Determinants of pharmaceutical pricesPolicies that promote fair
pricing of pharmaceuticals (Anthony So, Rockefeller
Foundation-Confirmed)
2. Research as a determinant of drug costs (Graham Dukes,
Norway-Confirmed)
3. Medicines: The price people pay (Margaret Ewen, HAI, The
Netherlands-Confirmed)
4. A new approach to measuring drug prices: The WHO/HAI drug
pricing project. Results of the South African pilot study. (Aarti
Kishuna, South Africa-Confirmed)
5. Pricing of pharmaceuticals in Tanzania (M. H. S. Chambuso,
Muhimbili University, Tanzania-Confirmed)
6. How can consumers get the best prices? (Zafar Mirza,
Pakistan-Invited)
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug